Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Intellectual Disability Research : JIDR
|
September 15, 2012
Therapy service use among individuals with fragile X syndrome: findings from a US parent survey
G E Martin, K K Ausderau, M Raspa, et al.
Veterinary and Comparative Oncology
|
August 19, 2011
Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy*
E K Malone, K M Rassnick, D B Bailey, et al.
Veterinary and Comparative Oncology
|
June 29, 2010
Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs
K M Rassnick, R Al-Sarraf, D B Bailey, et al.
Journal of Autism and Developmental Disorders
|
February 5, 1999
Autistic behavior in young boys with fragile X syndrome
D B Bailey, G B Mesibov, D D Hatton, et al.
Biochemistry
|
October 28, 1980
Cadmium-113 nuclear magnetic resonance investigation of metal binding sites in concanavalin A
A R Palmer, D B Bailey, W D Benhke, et al.
Journal of Veterinary Internal Medicine
|
November 13, 2008
Efficacy of vinblastine for treatment of canine mast cell tumors
K M Rassnick, D B Bailey, A B Flory, et al.
American Journal of Mental Retardation : AJMR
|
December 14, 1999
Needs and supports reported by Latino families of young children with developmental disabilities
D B Bailey, D Skinner, V Correa, et al.
Journal of Veterinary Internal Medicine
|
February 5, 2009
Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs
K M Rassnick, A S Moore, K E Collister, et al.
Journal of Veterinary Internal Medicine
|
February 22, 2008
Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs
A B Flory, K M Rassnick, R Al-Sarraf, et al.
Journal of Veterinary Internal Medicine
|
December 15, 2010
Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma
K M Rassnick, A S Moore, D S Russell, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Intellectual Disability Research : JIDR
|
September 15, 2012
Therapy service use among individuals with fragile X syndrome: findings from a US parent survey
G E Martin, K K Ausderau, M Raspa, et al.
Veterinary and Comparative Oncology
|
August 19, 2011
Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy*
E K Malone, K M Rassnick, D B Bailey, et al.
Veterinary and Comparative Oncology
|
June 29, 2010
Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs
K M Rassnick, R Al-Sarraf, D B Bailey, et al.
Journal of Autism and Developmental Disorders
|
February 5, 1999
Autistic behavior in young boys with fragile X syndrome
D B Bailey, G B Mesibov, D D Hatton, et al.
Biochemistry
|
October 28, 1980
Cadmium-113 nuclear magnetic resonance investigation of metal binding sites in concanavalin A
A R Palmer, D B Bailey, W D Benhke, et al.
Journal of Veterinary Internal Medicine
|
November 13, 2008
Efficacy of vinblastine for treatment of canine mast cell tumors
K M Rassnick, D B Bailey, A B Flory, et al.
American Journal of Mental Retardation : AJMR
|
December 14, 1999
Needs and supports reported by Latino families of young children with developmental disabilities
D B Bailey, D Skinner, V Correa, et al.
Journal of Veterinary Internal Medicine
|
February 5, 2009
Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs
K M Rassnick, A S Moore, K E Collister, et al.
Journal of Veterinary Internal Medicine
|
February 22, 2008
Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs
A B Flory, K M Rassnick, R Al-Sarraf, et al.
Journal of Veterinary Internal Medicine
|
December 15, 2010
Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma
K M Rassnick, A S Moore, D S Russell, et al.
Page
of 5